Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872421 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 5 Pages |
Abstract
Conclusions: The results of radiation monotherapy for PCNSL appear to have improved as compared with those reported previously. The results of new treatment should be evaluated in light of this finding. Since most prospective studies on the combined treatment exclude poor PS and high-age patients, the 5-year survival rate of 30% may not be regarded as a marked improvement over radiation alone.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yuta M.D., Hiroyuki M.D., Masatoshi M.D., Kazunori M.D., Masamichi M.D., Takashi M.D., Eriko M.D., Shun-Ichi M.D., Mitsuharu M.D., Masahiro M.D., Toshiki M.D., Naofumi M.D.,